Latest Sitaxentan Stories
RnRMarketResearch.com adds "Pulmonary Hypertension - Pipeline Review, H1 2015" to its store.
SARATOGA, Calif., March 18, 2015 /PRNewswire/ -- Selten Pharma, Inc., a privatively held biopharmaceutical company focused
A new study significantly improves understanding of how widely used drugs in pulmonary arterial hypertension (PAH) affect the heart health of patients who use them.
SAN DIEGO, May 4, 2011 /PRNewswire/ -- Aires Pharmaceuticals, Inc. today announced the hiring of Ed Parsley, D.O. as Chief Medical Officer. Dr.
WESTMINSTER, Colo., May 4, 2011 /PRNewswire/ -- Plato BioPharma, Inc. (PBI) and Gilead Sciences, Inc.
A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis (IPF).
- The abrogation of a law by a higher authority; annulment.